Lonza Group (LTS:0QNO) Scaled Net Operating Assets : 0.66 (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Lonza Group Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lonza Group's operating assets for the quarter that ended in Jun. 2024 was CHF15,867 Mil. Lonza Group's operating liabilities for the quarter that ended in Jun. 2024 was CHF4,675 Mil. Lonza Group's Total Assets for the quarter that ended in Dec. 2023 was CHF16,848 Mil. Therefore, Lonza Group's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.66.

Lonza Group Scaled Net Operating Assets Historical Data

The historical data trend for Lonza Group's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Scaled Net Operating Assets Chart

Lonza Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.71

0.74

0.65

0.67

0.63

Lonza Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.61	0.66	0.64	0.62	0.66

Competitive Comparison of Lonza Group's Scaled Net Operating Assets

For the Diagnostics & Research subindustry, Lonza Group's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lonza Group's Scaled Net Operating Assets Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Lonza Group's Scaled Net Operating Assets falls into.

Lonza Group Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Lonza Group's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(15180	-	4204)	/	17356
=	0.63

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	16848	-	1668
=	15180

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	7336	-	2905	-	227
=	4204

Lonza Group's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(15867	-	4675)	/	16848
=	0.66

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	17884	-	2017
=	15867

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	8470	-	3640	-	155
=	4675

Lonza Group Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Lonza Group's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (LTS:0QNO) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

LZAGY:USA LZAGF:USA LONN:Mexico LONNz:UK LO3A:Germany LONNE:Switzerland LONN:Switzerland

Address

Muenchensteinerstrasse 38, Basel, CHE, CH-4002

Website

https://www.lonza.com

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

Lonza Group Headlines

No Headlines